Photodynamic therapy dosimetry: current status and the emerging challenge of immune stimulation
This article is not a comprehensive review, but rather intended to recognize past advances and current limitations, and to stimulate discussion of future directions in PDT dosimetry. Inadequate dosimetry may be a potential impediment to PDT adoption and may have contributed to the failure of some previous and ongoing clinical trials.
Authors
- Robert Weersink (ORCID: https://orcid.org/0000-0002-3411-7288)
- Lothar Lilge (ORCID: https://orcid.org/0000-0001-5533-0005)
- Brian C. Wilson (ORCID: https://orcid.org/0000-0001-5543-666X)
- Layla Pires (ORCID: https://orcid.org/0000-0003-4558-5199)
Institutions
- University of Toronto (CA)
- Princess Margaret Cancer Centre (CA)
- Texas A&M University (US)
Publication Details
- Journal
- Journal of Biomedical Optics
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1117/1.jbo.30.s3.s34118
- Primary Topic
- Photodynamic Therapy Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00